Career Development Program: Scholar & Scholar in Clinical Research

Leukemia & Lymphoma Society

Grant amount: US $110,000

Next anticipated deadline: Sep 1, 2018 12:00pm PDT (Letter of inquiry)

Later anticipated deadlines: Sep 15, 2018 12:00pm PDT (Pre proposal), Oct 3, 2018 12:00pm PDT (Full proposal)

Applicant type: Faculty

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Degree requirements: Applicants must be within a few years of receiving their PhD

View website    Save Need help writing this grant?

Overview:

About the Leukemia & Lymphoma Society, Inc.

The Leukemia & Lymphoma Society, Inc. (LLS) is a national voluntary health agency dedicated to the conquest of hematologic malignancies and relevant premalignant conditions. LLS supports research, patient aid, community service programs, advocacy, and public and professional education.

Description of Awards

Through the Career Development Program, LLS supports talented blood cancer researchers in the early phase of their careers. CDP continues to provide a pool of dedicated researchers to advance the understanding and diagnosis of cancer, as well as the development of treatment and prevention options that will ultimately lead to cures for blood cancer patients. CDP funding is limited to salary support for the Applicant, but may be supplemented by funds from other appropriate sources as determined by the Grantee’s Sponsoring Institution. Support for research-associated costs must be provided by another source.

The Scholar & Scholar in Clinical Research Award

The Award is for 5 years. The maximum award per year is $110,000 and includes the Applicant’s salary and fringe benefits. Indirect costs may be included, and cannot exceed 5% of the total direct costs requested in the proposal. Expenditures for laboratory costs/equipment, travel, etc. are not permitted. The awarded value will be limited to the amount requested in the submitted proposal. It is anticipated that the proposed research will occupy a majority of the applicant’s research time. However, there are no requirements for a certain percent effort in our budget template. 

You can learn more about this opportunity by visiting the funder's website.

Eligibility:

  • Citizenship: LLS welcomes applications from both US citizens and non-citizens, as well as applicants who are performing research outside the U.S. Degree
  • Degree: Applicants must hold a PhD, MD, DVM, or equivalent degree.
  • Scholar Applicants:
    • Must hold an independent position, and have held an independent position for less than or equal to 8 years as of January 1, 2018; all independent positions are counted (Instructor level positions are not counted as independent for eligibility).
    • Must have a significant history of blood cancer-relevant publications.
    • Must propose research directly relevant to blood cancer.
    • Must be the PI on a nationally-awarded grant (peer-reviewed, national level; R01-equivalent) that supports the research proposed and that extends beyond the Award start date.
    • Must have a Sponsor who will attest to the Sponsoring Institution’s commitment to the applicant’s career. 
  • Clinical Research Applicants:
    • Must hold an independent position, and have held an independent position for less than or equal to 10 years as of January 1, 2018; all independent positions are counted (Instructor level positions are not counted as independent for eligibility).
    • Must have a significant history of blood cancer-relevant publications.
    • Must propose research directly related to the clinic.
    • Must be the PI on a nationally-awarded grant (peer-reviewed, national level; R01-equivalent) that supports the research proposed and that extends beyond the Award start date.
    • Must have a Sponsor who will attest to the Sponsoring Institution’s commitment to the applicant’s career.
    • The proposed studies should translate new concepts in the biomedical, epidemiological, or preventative sciences into clinical practice.
      • Any proposed clinical research should be independently developed and implemented by the applicant.
      • Ongoing collaborations and sponsorships of clinical research by an industry source are acceptable
  • Applicants must be affiliated with a non-profit Sponsoring Institution at the time funding commences and for the duration of the award. 
    • All Scholar Applicants must have a Sponsor with a full time appointment at the applicant’s institution.
  • Applicants may only submit one application.
  • There is no limit to the number of applications submitted from a specific institution, nor is there a limit to the number of Scholar applications on which a Sponsor is listed. 

Preferences:

  • Clinical Research Applicants: Preference will be given to applicants whose research involves an early phase clinical trial of new or innovative therapies. 

Ineligibility:

  • Thee Scholar Award & Scholar in Clinical Research Award is intended to further develop the careers of early-stage investigators; this Award is not intended for well-established and/or senior investigators.
  • Expenditures for laboratory costs/equipment, travel, etc. are not permitted.
  • No other comparable or better career development award (as measured by the total award amount) may be held prior to, or at the time of the Award start date. If a comparable (or better) career development award is activated after receiving a Fellow Award, the LLS Award must be relinquished. 
  • Research Support Requirement: Research support that ends prior to the Award start date may not be used as evidence of adequate support

Suggest an update